Clinical Trial Update: A Study Evaluating the Safety and Efficacy of Lovo-cel in Severe Sickle Cell Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the safety and efficacy of Lovo-cel in severe sickle cell disease has completed, with results posted on 2024-10-08.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Lovo-cel

Snippet

Sponsor: Genetix Biotherapeutics Inc. | Conditions: Sickle Cell Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-10-08